Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. (31st January 2022)

Record Type:: Journal Article
Title:: Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. (31st January 2022)
Main Title:: Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
Authors:: Griesel, Rulan
Maartens, Gary
Chirehwa, Maxwell
Sokhela, Simiso
Akpomiemie, Godspower
Moorhouse, Michelle
Venter, Francois
Sinxadi, Phumla
Abstract:
Is Part Of:: Clinical infectious diseases. Volume 74:Number 4(2022)
Journal:: Clinical infectious diseases
Issue:: Volume 74:Number 4(2022)
Issue Display:: Volume 74, Issue 4 (2022)
Year:: 2022
Volume:: 74
Issue:: 4
Issue Sort Value:: 2022-0074-0004-0000
Page Start:: 755
Page End:: 755
Publication Date:: 2022-01-31
Subjects:: Communicable diseases -- Periodicals
616.905
Journal URLs:: http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗
DOI:: 10.1093/cid/ciab804 ↗
Languages:: English
ISSNs:: 1058-4838
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 20752.xml